Dennis J. Wright
Chief Tech/Sci/R&D Officer at CLINUVEL PHARMACEUTICALS LIMITED
Net worth: 1 M $ as of 2024-03-30
Profile
Dennis J.
Wright is currently the Chief Scientific Officer at Clinuvel Pharmaceuticals Ltd.
He previously worked as the Manager-Global Pharmacovigilance at Mayne Pharma Ltd.
Dr. Wright completed his undergraduate and graduate degrees at The University of Sydney.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-08-14 | 156,874 ( 0.31% ) | 1 M $ | 2024-03-30 |
Dennis J. Wright active positions
Companies | Position | Start |
---|---|---|
CLINUVEL PHARMACEUTICALS LIMITED | Chief Tech/Sci/R&D Officer | - |
Former positions of Dennis J. Wright
Companies | Position | End |
---|---|---|
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Mayne Pharma Ltd. manufactures pharmaceutical products. It distributes generic injectables for the oncology market. The company's competitors include Sandoz, Bedford Labs, and Ebewe. It was founded in November 2005 and is headquartered in Melbourne, Australia. | General Counsel | - |
Training of Dennis J. Wright
The University of Sydney | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CLINUVEL PHARMACEUTICALS LIMITED | Health Technology |
Private companies | 1 |
---|---|
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Mayne Pharma Ltd. manufactures pharmaceutical products. It distributes generic injectables for the oncology market. The company's competitors include Sandoz, Bedford Labs, and Ebewe. It was founded in November 2005 and is headquartered in Melbourne, Australia. | Health Technology |
- Stock Market
- Insiders
- Dennis J. Wright